Loading the company…
Loading the company…
Families: Lumbar fusion, Bone graft & orthobiologics, Cervical fusion & disc arthroplasty, Hernia repair.
All companies · Product and company coverage
In the last ten years FDA made 3 decisions for Rti Surgical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 4 procedure families, the most in 2017 (2). The latest was on 2025-02-21.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 2 |
| Bone graft & orthobiologics | 1 |
| Cervical fusion & disc arthroplasty | 1 |
| Hernia repair | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-02-21 | 510(k) | K241555 | Moldable Bone Void Filler and Moldable Bone Void Filler + CCC |
| 2017-10-23 | 510(k) | K172343 | Fortilink® Interbody Fusion (IBF) System with TETRAfuse® 3D Technology |
| 2017-05-23 | 510(k) | K163673 | Fortilink-C with TETRAfuse 3D Technology |
| 2014-10-27 | 510(k) | K142070 | FORTIVA PORCINE DERMIS, TUTOPLAST PORCINE DERMIS |
In 2025, Rti Surgical reported engagement with 561 surgeons and other clinicians in the states MedaRep covers, worth $916K in consulting, speaking, meals and travel for its device products, the most in New Jersey ($327K to 15). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: New Jersey ($327K, 15 engaged), Florida ($190K, 23 engaged), North Carolina ($102K, 14 engaged), California ($56K, 82 engaged), Pennsylvania ($40K, 38 engaged).
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Rti Surgical.